These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 831285)

  • 1. Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes.
    Needleman P; Kulkarni PS; Raz A
    Science; 1977 Jan; 195(4276):409-12. PubMed ID: 831285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery.
    Svensson J; Hamberg M
    Prostaglandins; 1976 Dec; 12(6):943-50. PubMed ID: 1005743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.
    Dusting GJ; Moncada S; Vane JR
    Prostaglandins; 1977 Jan; 13(1):3-15. PubMed ID: 841106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral arterial smooth muscle contraction by thromboxane A2.
    Ellis EF; Nies AS; Oates JA
    Stroke; 1977; 8(4):480-3. PubMed ID: 898244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV; Johnson RA; Gorman RR
    Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate.
    Kulkarni PS; Roberts R; Needleman P
    Prostaglandins; 1976 Sep; 12(3):337-53. PubMed ID: 968049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.
    Ellis EF; Oelz O; Roberts LJ; Payne NA; Sweetman BJ; Nies AS; Oates JA
    Science; 1976 Sep; 193(4258):1135-7. PubMed ID: 959827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of prostaglandins on isolated perfused cat coronary arteries.
    Ogletree ML; Smith JB; Lefer AM
    Am J Physiol; 1978 Oct; 235(4):H400-6. PubMed ID: 696881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator.
    Raz A; Isakson PC; Minkes MS; Needleman P
    J Biol Chem; 1977 Feb; 252(3):1123-6. PubMed ID: 838699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.
    Higgs GA; Bunting S; Moncada S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):749-57. PubMed ID: 981700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.
    Needleman P; Moncada S; Bunting S; Vane JR; Hamberg M; Samuelsson B
    Nature; 1976 Jun; 261(5561):558-60. PubMed ID: 934294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxanes: selective biosynthesis and distinct biological properties.
    Needleman P; Minkes M; Raz A
    Science; 1976 Jul; 193(4248):163-5. PubMed ID: 945611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of endoperoxides and thromboxanes in anaphylactic reactions.
    Hamberg M; Svensson J; Hedqvist P; Strandberg K; Samuelsson B
    Adv Prostaglandin Thromboxane Res; 1976; 1():495-501. PubMed ID: 998440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.